China Atrial Fibrillation Market Size & Outlook, 2023-2030

The atrial fibrillation market in China is expected to reach a projected revenue of US$ 3,026.7 million by 2030. A compound annual growth rate of 11.7% is expected of China atrial fibrillation market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,396.3
Forecast, 2030 (US$M)
$3,026.7
CAGR, 2024 - 2030
11.7%
Report Coverage
China

China atrial fibrillation market highlights

  • The China atrial fibrillation market generated a revenue of USD 1,396.3 million in 2023 and is expected to reach USD 3,026.7 million by 2030.
  • The China market is expected to grow at a CAGR of 11.7% from 2024 to 2030.
  • In terms of segment, pharmacological was the largest revenue generating treatment type in 2023.
  • Pharmacological is the most lucrative treatment type segment registering the fastest growth during the forecast period.


Atrial fibrillation market data book summary

Market revenue in 2023USD 1,396.3 million
Market revenue in 2030USD 3,026.7 million
Growth rate11.7% (CAGR from 2023 to 2030)
Largest segmentPharmacological
Fastest growing segmentPharmacological
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPharmacological, Non Pharmacological
Key market players worldwideAtriCure Inc, Boehringer Ingelheim, Boston Scientific Corp, Bristol-Myers Squibb Co, Sanofi SA, Johnson & Johnson, Abbott Laboratories


Other key industry trends

  • In terms of revenue, China accounted for 5.7% of the global atrial fibrillation market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan atrial fibrillation market is projected to lead the regional market in terms of revenue in 2030.
  • Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 471.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Atrial Fibrillation Market Scope

Atrial fibrillation market segmentation & scope
Anti-arrythmic
Anti-coagulant
Catheter Ablation Procedures
Maze surgery
Electric Cardioversion
Radiofrequency
HIFU
Cryoablation
Microwave
Laser
Hospitals
Speciality Clinics
Others

Atrial Fibrillation Market Companies

Name Profile # Employees HQ Website

China atrial fibrillation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atrial fibrillation market will help companies and investors design strategic landscapes.


Pharmacological was the largest segment with a revenue share of 66.1% in 2023. Horizon Databook has segmented the China atrial fibrillation market based on pharmacological, non pharmacological covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China atrial fibrillation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China atrial fibrillation market databook

  • Our clientele includes a mix of atrial fibrillation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China atrial fibrillation market , including forecasts for subscribers. This country databook contains high-level insights into China atrial fibrillation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China atrial fibrillation market size, by treatment type, 2018-2030 (US$M)

China Atrial Fibrillation Market Outlook Share, 2023 & 2030 (US$M)

China atrial fibrillation market size, by treatment type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more